Delivery Order SPE2DB20D2002-SPE2DB25FL17P

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,713.68, is for the delivery of MULTAQ 400 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger IDC with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,034.70 firm fixed price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a cardiovascular medication. The ultimate completion date is November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,467.70, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through January 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a total ceiling value of $6,916.35 and is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to support military healthcare programs. The contract does not have a set-aside designation, indicating it was open to all qualified offerors. In addition to this delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,504,610 MULTAQ 400 MG TABLET 60S. The contract has an ultimate completion date of August 20, 2024 and a ceiling value of $8,771.60. It is a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,182.80, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of January 10, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price of $42,514.13 and a period of performance through August 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,430.70 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA) to provide MULTAQ 400 MG tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $12,034.92 and is a firm fixed-price contract type, with an ultimate completion date of February 4, 2025. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,451.96, is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 15, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
  • SPE2DB20D2002
    Indefinite Delivery Contract
  • SPE2DB20D2002-SPE2DB25FL17P
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,042.08, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This contract award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems.

Generated 5/5/25, 9:54 AM